Back to Results
First PageMeta Content
Iron metabolism / Blood / Anemias / Hepatology / Hepcidin / Erythropoietin / Ferroportin / Anemia of chronic disease / Human iron metabolism / Medicine / Biology / Hematology


PRESS RELEASE First Data from NOXXON’s NOX-H94 (Lexaptepid Pegol) Clinical Trial in ESA-Hyporesponsive Dialysis Patients Reported at ERA-EDTA Conference Berlin, Germany and Boston, USA - May 29, NOXXON Pharma a
Add to Reading List

Document Date: 2015-05-27 04:50:40


Open Document

File Size: 274,79 KB

Share Result on Facebook
UPDATE